Predictors of Recurrence and Survival in Resectable Distal Pancreatic Cancer

被引：0
|
作者：
Zureikat, Amer H.
Hammad, Abdulrahman Y.
Liu, Hao
Narayan, Jeyani
Khachfe, Hussein H.
AlMasri, Samer
DeSilva, Annissa
Lee, Kenneth K.
Paniccia, Alessandro
机构：
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V47
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [1] Preoperative predictors for early recurrence of resectable pancreatic cancer
    Kohei Nishio
    Kenjiro Kimura
    Ryosuke Amano
    Sadaaki Yamazoe
    Go Ohrira
    Bunzo Nakata
    Kosei Hirakawa
    Masaichi Ohira
    [J]. World Journal of Surgical Oncology, 15
  • [2] Preoperative predictors for early recurrence of resectable pancreatic cancer
    Nishio, Kohei
    Kimura, Kenjiro
    Amano, Ryosuke
    Yamazoe, Sadaaki
    Ohrira, Go
    Nakata, Bunzo
    Hirakawa, Kosei
    Ohira, Masaichi
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [3] Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
    Imamura, Masafumi
    Nagayama, Minoru
    Kyuno, Daisuke
    Ota, Shigenori
    Murakami, Takeshi
    Kimura, Akina
    Yamaguchi, Hiroshi
    Kato, Toru
    Kimura, Yasutoshi
    Takemasa, Ichiro
    [J]. CANCERS, 2021, 13 (10)
  • [4] Tumor Size and Not Radiologic Splenic Vessel Involvement Is Predictive of Survival in Resectable Distal Pancreatic Cancer
    Rangelova, Elena B.
    Oba, Atsushi
    Lafaro, Kelly J.
    Javed, Ammar A.
    Wolfgang, Christopher L.
    Inoue, Yosuke
    He, Jin
    Del Chiaro, Marco
    Schulick, Richard D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S307 - S308
  • [5] The role of Ca 19-9 in progression, recurrence and survival of borderline resectable pancreatic cancer
    Almeida, C.
    Goncalves, M.
    Freitas, M.
    Teixeira, C.
    Couto, M.
    Lemos, T.
    Meireles, S.
    Rego, I.
    Sarmento, C.
    Coelho, A.
    Costa, A.
    Barbosa, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S143 - S144
  • [6] Predictors of recurrence and implications for overall survival in borderline resectable pancreatic cancer patients treated with total neoadjuvant therapy: A retrospective cohort study.
    Kaplan, Jori Lee
    Powers, Benjamin
    Fan, Wenyi
    Schell, Michael J.
    Centeno, Barbara
    Kim, Dae Won
    Frakes, Jessica
    Hoffe, Sarah E.
    Malafa, Mokenge Peter
    Hodul, Pamela Joy
    Fleming, Jason B.
    Carballido, Estrella M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients
    Lee, Sang Hyub
    Kim, Haeryoung
    Hwang, Jin-Hyeok
    Lee, Hye Seung
    Cho, Jai Young
    Yoon, Yoo-Seok
    Han, Ho-Seong
    [J]. PATHOLOGY INTERNATIONAL, 2012, 62 (03) : 167 - 175
  • [8] Clinicopathological Predictive Factors for Early Recurrence in Resectable Pancreatic Cancer
    Kimura, R.
    Miyasaka, Y.
    Mori, Y.
    Nakata, K.
    Ohtsuka, T.
    Nakamura, M.
    [J]. PANCREAS, 2019, 48 (10) : 1462 - 1462
  • [9] The Association Between Elevated CA 19-9 and Recurrence, Site of Recurrence, and Overall Survival in Upfront Resectable Pancreatic Cancer
    Powers, B.
    Kim, J. K.
    Deperalta, D. K.
    Ogami, T.
    Pimiento, J.
    Hodul, P. J.
    Malafa, M. P.
    Fleming, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S145 - S146
  • [10] Survival of resectable pancreatic cancer patients with diabetes.
    Busaidy, N. L.
    Yazbeck, C. F.
    Shah, P.
    Evans, D. B.
    Li, D.
    Geraci, J. M.
    Weiser, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 202S - 202S
12345